# A Two-part Trial Assessing the Effects of 7α-methyl-19-nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-label Pilot Study Followed by a Randomized, Double-blind, Placebo-controlled Study

> **NCT00812630** · PHASE1 · COMPLETED · sponsor: **Population Council** · enrollment: 68 (actual)

## Conditions studied

- Blood Pressure

## Interventions

- **DRUG:** MENT or placebo

## Key facts

- **NCT ID:** NCT00812630
- **Lead sponsor:** Population Council
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812630, "A Two-part Trial Assessing the Effects of 7α-methyl-19-nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-label Pilot Study Followed by a Randomized, Double-blind, Placebo-controlled Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00812630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*